Scotts Miracle-Gro (NYSE: SMG) insider transactions
In the twelve months to 10 November 2026, executives and directors of Scotts Miracle-Gro reported 5 open-market sales of 82,002 shares ($5.5m) and 1 open-market purchase of 693 shares ($49,508), by 4 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 28 October 2026 | Baxter Nathan Eric | President and CEO | Grant or award | +23,872 | — | 102,315 | Form 4 |
| 28 October 2026 | Scheiwer Mark J | EVP, CFO & CAO | Grant or award | +2,163 | — | 16,497 | Form 4 |
| 28 October 2026 | Todorov Dimiter | EVP, Clo & Corporate Secretary | Grant or award | +9,947 | — | 28,961 | Form 4 |
| 2 October 2026 | Scheiwer Mark J | EVP, CFO & CAO | Shares withheld for tax | −1,559 | $49.02 | 13,834 | Form 4 |
| 1 October 2026 | Johnson Stephen L | Director | Grant or award | +144 | — | 30,323 | Form 4 |
| 1 October 2026 | Sandoval Brian E | Director | Grant or award | +575 | — | 20,190 | Form 4 |
| 30 September 2026 | Scheiwer Mark J | EVP, CFO & CAO | Other | +3 | $45.88 | 15,393 | Form 4 |
| 5 September 2026 | Baxter Nathan Eric | President and CEO | Shares withheld for tax | −12,023 | $57.53 | 78,443 | Form 4 |
| 31 August 2026 | Hagedorn Christopher | EVP & Chief Strategy Officer | Other | +4 | $53.41 | 57,556 | Form 4 |
| 31 August 2026 | Scheiwer Mark J | EVP, CFO & CAO | Other | +3 | $53.41 | 15,389 | Form 4 |
| 10 August 2026 | Kingdon Mark D | Director | Open-market sale | −831 | $61.65 | 10,827 | Form 4 |
| 3 August 2026 | Hagedorn Partnership, L.P. | Director | Open-market sale | −28,793 | $67.42 | 13,138,848 | Form 4 |
| 3 August 2026 | Hagedorn Partnership, L.P. | Director | Open-market sale | −1,207 | $68.16 | 13,137,641 | Form 4 |
| 31 July 2026 | Hagedorn Christopher | EVP & Chief Strategy Officer | Other | +4 | $56.55 | 57,552 | Form 4 |
| 31 July 2026 | Baxter Nathan Eric | President and CEO | Other | +88 | $56.55 | 90,466 | Form 4 |
| 31 July 2026 | Scheiwer Mark J | EVP, CFO & CAO | Other | +3 | $56.55 | 15,387 | Form 4 |
| 30 July 2026 | Johnson Stephen L | Director | Open-market sale | −1,171 | $68.32 | 30,179 | Form 4 |
| 1 July 2026 | Johnson Stephen L | Director | Grant or award | +105 | $68.57 | 31,350 | Form 4 |
| 1 July 2026 | Sandoval Brian E | Director | Grant or award | +420 | $68.57 | 19,615 | Form 4 |
| 1 July 2026 | Baxter Nathan Eric | President and CEO | Grant or award | +29,168 | — | 90,377 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Scotts Miracle-Gro page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.